September 20, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Bioscovy (emtricitabine 200mg/ tenofovir alafenamide 25mg) tablet for customers, each box of Bioscovy includes 30 tablets. It is a tablet taken by mouth. Bioscovy for PrEP (pre-exposure prophylaxis) is a once-daily prescription medicine for adults and adolescents at risk of HIV. Bioscovy for PrEP is not for everyone: It is not…
September 14, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") launches New Product Packaging for SaiLin's Global Market Customers. This product packaging upgrade is to fulfill the previous promise of BioSpring's acquisition of SaiLin, and will continue to provide follow-up support and services to Sailin's global customers. The batch will use Biospring's anti-counterfeiting verification system. Including the following 7 anticancer drug…
September 08, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Tadazen (tadalafil) tablet for customers, which will be available in a single strength of 20mg, and each box of tadazen includes 8 tablets.It is a tablet taken by mouth. Onset is typically within half an hour and the duration is up to 36 hours. This product is manufactured and produced by…
September 07, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") announces coommerical packaging solutions for formulation manufacturing. Completing the prefabrication process for this commercial package ahead of time will help shorten the overall manufacturing cycle. Samuel, founder and CEO of BioSpring, said: “BioSpring can help customers overcome the challenges of formulating, processing and scaling up manufacturing of generic drugs.” Days it takes…
